Plain Votes

U.S. House · 119th Congress · H.R. 10094

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026

To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
Val T. HoyleD-OR-4
Introduced
August 13, 2026, in the House
Issue areas
Policy area
Health (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (15)

15 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these

Original cosponsors

Signed on later